Siu LL - Search Results

1

Simultaneous determination of OSI-774 and its major metabolite OSI-420 in human plasma by using HPLC with UV detection.

Zhang W, Siu LL, Moore MJ, Chen EX. Zhang W, et al. Among authors: siu ll. J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Jan 5;814(1):143-7. doi: 10.1016/j.jchromb.2004.10.016. J Chromatogr B Analyt Technol Biomed Life Sci. 2005. PMID: 15607718

2

Other chemotherapy regimens including mitoxantrone and suramin.

Siu LL, Moore MJ. Siu LL, et al. Semin Urol Oncol. 1997 Feb;15(1):20-7. Semin Urol Oncol. 1997. PMID: 9050136 Review.

3

Use of the somatostatin analogue octreotide acetate in the treatment of encephalopathy associated with carcinoid tumor. Case report.

Siu LL, Chapman W, Moore MJ. Siu LL, et al. Am J Clin Oncol. 1997 Dec;20(6):558-61. doi: 10.1097/00000421-199712000-00004. Am J Clin Oncol. 1997. PMID: 9391539

4

Phase I and pharmacologic study of 9-aminocamptothecin colloidal dispersion formulation given as a 24-hour continuous infusion weekly times four every 5 weeks.

Siu LL, Oza AM, Eisenhauer EA, Firby PS, Thiessen JJ, Michael M, Wainman N, Manzo J, Feld R, Goldberg RA, Moore MJ. Siu LL, et al. J Clin Oncol. 1998 Mar;16(3):1122-30. doi: 10.1200/JCO.1998.16.3.1122. J Clin Oncol. 1998. PMID: 9508199 Clinical Trial.

5

The prognostic role of p53, metallothionein, P-glycoprotein, and MIB-1 in muscle-invasive urothelial transitional cell carcinoma.

Siu LL, Banerjee D, Khurana RJ, Pan X, Pflueger R, Tannock IF, Moore MJ. Siu LL, et al. Clin Cancer Res. 1998 Mar;4(3):559-65. Clin Cancer Res. 1998. PMID: 9533522

6

Use of mesna to prevent ifosfamide-induced urotoxicity.

Siu LL, Moore MJ. Siu LL, et al. Support Care Cancer. 1998 Mar;6(2):144-54. doi: 10.1007/s005200050149. Support Care Cancer. 1998. PMID: 9540174 Review.

7

A phase II study of temozolomide in advanced untreated pancreatic cancer.

Moore MJ, Feld R, Hedley D, Oza A, Siu LL. Moore MJ, et al. Among authors: siu ll. Invest New Drugs. 1998;16(1):77-9. doi: 10.1023/a:1006043332368. Invest New Drugs. 1998. PMID: 9740547 Clinical Trial.

8

Phase I dose-finding and pharmacokinetic study of paclitaxel and carboplatin with oral valspodar in patients with advanced solid tumors.

Patnaik A, Warner E, Michael M, Egorin MJ, Moore MJ, Siu LL, Fracasso PM, Rivkin S, Kerr I, Litchman M, Oza AM. Patnaik A, et al. Among authors: siu ll. J Clin Oncol. 2000 Nov 1;18(21):3677-89. doi: 10.1200/JCO.2000.18.21.3677. J Clin Oncol. 2000. PMID: 11054441 Clinical Trial.

9

Phase I and pharmacokinetic study of novel L-nucleoside analog troxacitabine given as a 30-minute infusion every 21 days.

Bélanger K, Moore M, Baker SD, Dionne J, Maclean M, Jolivet J, Siu L, Soulières D, Wainman N, Seymour L. Bélanger K, et al. J Clin Oncol. 2002 May 15;20(10):2567-74. doi: 10.1200/JCO.2002.12.047. J Clin Oncol. 2002. PMID: 12011137 Clinical Trial.

10

Sucralfate mouthwash for prevention and treatment of 5-fluorouracil-induced mucositis: a randomized, placebo-controlled trial.

Nottage M, McLachlan SA, Brittain MA, Oza A, Hedley D, Feld R, Siu LL, Pond G, Moore MJ. Nottage M, et al. Among authors: siu ll. Support Care Cancer. 2003 Jan;11(1):41-7. doi: 10.1007/s00520-002-0378-8. Epub 2002 Jul 23. Support Care Cancer. 2003. PMID: 12527953 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

441 results

Search Page

Filters